Recombinant Human AK2 Protein，His

AK2, or adenylate kinase 2, is a crucial enzyme involved in cellular energy homeostasis as it plays a vital role in the ATP-ADP energy cycle. Research into AK2 has gained significance due to its involvement in various physiological and pathological processes, including mitochondrial function, cell proliferation, and apoptosis. Mutations or dysregulation of AK2 are implicated in several diseases, including tumorigenesis and mitochondrial disorders. Studies have shown that AK2 is predominantly localized in mitochondria, suggesting a pivotal role in bioenergetics and cellular metabolism. Furthermore, its expression levels can significantly influence cellular responses to stress and injury, making it a potential target for therapeutic interventions. Recent advances in recombinant protein technology have enabled researchers to produce AK2 in larger quantities and purify it for in-depth functional studies. This has facilitated the exploration of its biochemical properties, interactions with other cellular components, and the impact of post-translational modifications. Understanding AK2 at the molecular level may provide insights into its regulatory mechanisms and its potential role as a biomarker or therapeutic target for conditions associated with energy metabolism dysfunctions. Research initiatives focusing on AK2 also aim to elucidate its involvement in signaling pathways that govern cell survival and death, thereby bridging the gap between basic biochemistry and clinical applications in disease management. As studies continue to uncover the multifaceted roles of AK2, it stands as a promising candidate for future research in cellular bioenergetics and disease modeling.